Search Results for " Acalabrutinib "
Acalabrutinib Related Products
Acalabrutinib is a medication used to treat various types of non-Hodgkin lymphoma, including mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic Lymphoma (CLL/SLL). It is a type of targeted therapy known as a Bruton’s tyrosine kinase (BTK) inhibitor.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Acalabrutinib, pharmacopeial and non-pharmacopeial Acalabrutinib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Acalabrutinib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Acalabrutinib-related products are thoroughly characterized. Acalabrutinib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.